BRIEF published on 12/09/2024 at 23:05, 1 year 1 month ago Liberty Supports New Australian Businesses with Flexible Loans Business Loans Australian Market Economic Growth Liberty Financial Startup Support
BRIEF published on 12/09/2024 at 23:05, 1 year 1 month ago Liberty soutient les nouvelles entreprises australiennes avec des prêts flexibles Croissance Économique Marché Australien Prêts Aux Entreprises Financière Liberty Assistance Au Démarrage
BRIEF published on 12/09/2024 at 22:35, 1 year 1 month ago Gladstone Investment Corporation Unveils Notes Offering Nasdaq Listing Public Offering SEC Registration Notes Due 2030 Investment Proceeds
BRIEF published on 12/09/2024 at 22:35, 1 year 1 month ago Gladstone Investment Corporation dévoile son offre de billets Cotation Au Nasdaq Offre Publique De Vente Obligations À Échéance 2030 Produit De L'investissement Enregistrement Auprès De La SEC
BRIEF published on 12/09/2024 at 22:20, 1 year 1 month ago Nanobiotix conclut avec succès une étude de phase 1 sur le cancer du pancréas FDA Étude De Phase 1 Cancer Du Pancréas Chimiothérapie Radiothérapie
BRIEF published on 12/09/2024 at 22:20, 1 year 1 month ago Nanobiotix successfully completes phase 1 study in pancreatic cancer FDA Pancreatic Cancer Chemotherapy Phase 1 Study Radiotherapy
BRIEF published on 12/09/2024 at 22:10, 1 year 1 month ago AGLC Extends Increased Slot Commission for Gamehost Inc. Gamehost Inc. TSX:GH Slot Commission AGLC Alberta Gaming
BRIEF published on 12/09/2024 at 22:10, 1 year 1 month ago AGLC prolonge l'augmentation de la commission sur les machines à sous pour Gamehost Inc. Gamehost Inc. TSX:GH AGLC Commission Des Machines À Sous Jeux En Alberta
BRIEF published on 12/09/2024 at 22:10, 1 year 1 month ago Protagonist Therapeutics Reveals Promising Rusfertide Study Results at ASH 2024 Rusfertide Polycythemia Vera Phase 2 REVIVE Hematocrit Control ASH 2024
BRIEF published on 12/09/2024 at 22:10, 1 year 1 month ago Protagonist Therapeutics révèle des résultats prometteurs pour son étude sur le rusfertide à l'ASH 2024 Rusfertide Polycythémie Vraie Phase 2 REVIVE ASH 2024 Contrôle De L'hématocrite
Published on 01/20/2026 at 14:00, 21 minutes ago Colosseum Bankable Feasibility Study Advances to Final Stages
Published on 01/20/2026 at 14:00, 21 minutes ago CANEX Metals Responds to Gold Basin Resources' Last-Minute Attempt to Transfer Material Property to a Related Party
Published on 01/20/2026 at 14:00, 21 minutes ago Sankar Das Gupta Exercises Warrants to Acquire Common Shares of Electrovaya Inc.
Published on 01/20/2026 at 14:00, 21 minutes ago GameSquare Appoints Doug Rosen as Chief Commercial and Strategy Officer
Published on 01/20/2026 at 13:50, 31 minutes ago Polaris Renewable Energy Declares Quarterly Dividend
Published on 01/20/2026 at 14:15, 5 minutes ago Reju Announces Site Selection for First U.S. Industrial Sized Facility Regeneration Hub in Rochester, New York
Published on 01/20/2026 at 14:05, 15 minutes ago Syzygy Plasmonics Signs Landmark Commercial Offtake Agreement with Trafigura to Supply Advanced Sustainable Aviation Fuel
Published on 01/20/2026 at 07:30, 6 hours 51 minutes ago Gimv leidt een Series B investeringsronde van EUR 51 miljoen in Exciva voor verdere ontwikkeling van een innovatieve Alzheimerbehandeling
Published on 01/20/2026 at 07:30, 6 hours 51 minutes ago Gimv leads € 51 million Series B investment round in Exciva to advance innovative Alzheimer’s therapy
Published on 01/20/2026 at 07:30, 6 hours 51 minutes ago Gimv leads € 51 million Series B investment round in Exciva to advance innovative Alzheimer’s therapy
Published on 01/19/2026 at 17:45, 20 hours 36 minutes ago Calendrier de communication financière 2026
